via the multiplexed introduction of well-known loss-of-function CLL driver mutations (including Atm, Trp53, Samhd1, Mga, Birc3, and Chd2) into del(13q) murine B cells (26). The gene discussed is ATM; the disease is B-cell chronic lymphocytic leukemia.